Joel Greenblatt Gotham Asset Management
Joel Greenblatt is a co-founder of Gotham Asset Management and a well-known value investor, professor, and author. He gained wide recognition for The Little Book That Beats the Market and for popularizing a systematic value approach often called the “magic formula.” Greenblatt’s career spans special-situation investing, quantitative value strategies, and investor education.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BILL Holdings
BILL
|
+$41.5M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$35.9M |
| 3 |
Gotham Enhanced 500 ETF
GSPY
|
+$35.8M |
| 4 |
PayPal
PYPL
|
+$17.4M |
| 5 |
NATI
National Instruments Corp
NATI
|
+$12.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$14M |
| 2 |
Lam Research
LRCX
|
+$12.7M |
| 3 |
Meta Platforms (Facebook)
META
|
+$9.54M |
| 4 |
VMW
VMware, Inc
VMW
|
+$9.3M |
| 5 |
Valvoline
VVV
|
+$9.03M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.4% |
| 2 | Industrials | 12.68% |
| 3 | Consumer Discretionary | 10.55% |
| 4 | Healthcare | 8.73% |
| 5 | Financials | 6.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1076
Henry Schein
HSIC
$9.86B
| $374K | 0.01% |
4,942
-3,462
| -41% | -$242K |
|
1077
Texas Capital Bancshares
TCBI
$4.27B
| $374K | 0.01% |
5,786
-16
| -0.3% | -$922 |
|
1078
SentinelOne
S
$7.26B
| $374K | 0.01% |
13,612
-1,718
| -11% | -$33.3K |
|
1079
CBIZ
CBZ
$2.97B
| $371K | 0.01% |
5,922
-1,233
| -17% | -$69.6K |
|
1080
Donnelley Financial Solutions
DFIN
$1.19B
| $367K | 0.01% |
5,879
-133
| -2% | -$7.58K |
|
1081
Armstrong World Industries
AWI
$7.55B
| $366K | 0.01% |
3,722
-9,619
| -72% | -$795K |
|
1082
Rapid7
RPD
$799M
| $365K | 0.01% |
6,395
-359
| -5% | -$18.8K |
|
|
AVNS
1083
DELISTED
Avanos Medical
AVNS
| $363K | 0.01% |
+16,167
| New | +$334K |
|
1084
Dole
DOLE
$1.26B
| $360K | 0.01% |
29,326
+7,412
| +34% | +$85.6K |
|
1085
Factset
FDS
$10.7B
| $359K | 0.01% |
+752
| New | +$338K |
|
1086
Vail Resorts
MTN
$5.45B
| $358K | 0.01% |
1,679
-10,913
| -87% | -$2.39M |
|
1087
Ultragenyx Pharmaceutical
RARE
$2.55B
| $358K | 0.01% |
+7,478
| New | +$290K |
|
1088
Americold
COLD
$4.35B
| $354K | 0.01% |
11,703
-39,678
| -77% | -$1.11M |
|
1089
Kontoor Brands
KTB
$4.48B
| $354K | 0.01% |
+5,670
| New | +$291K |
|
1090
Ionis Pharmaceuticals
IONS
$9.93B
| $354K | 0.01% |
6,989
-1,099
| -14% | -$52.6K |
|
1091
Brookdale Senior Living
BKD
$2.82B
| $352K | 0.01% |
60,500
+15,491
| +34% | +$72.7K |
|
1092
Independent Bank
INDB
$3.97B
| $351K | 0.01% |
5,334
-65
| -1% | -$3.59K |
|
|
RYZ
1093
Ryerson Holding Corp
RYZ
$1.31B
| $350K | 0.01% |
10,103
+2,863
| +40% | +$85.3K |
|
1094
Perdoceo Education
PRDO
$2.07B
| $350K | 0.01% |
19,923
+810
| +4% | +$14.3K |
|
1095
Principal Financial Group
PFG
$23.7B
| $349K | 0.01% |
+4,440
| New | +$322K |
|
1096
Blue Bird Corp
BLBD
$1.96B
| $349K | 0.01% |
12,948
-6,745
| -34% | -$139K |
|
1097
Ingles Markets
IMKTA
$1.61B
| $346K | 0.01% |
4,010
+649
| +19% | +$52.8K |
|
1098
Adeia
ADEA
$2.89B
| $343K | 0.01% |
27,720
-7,928
| -22% | -$76.5K |
|
1099
BridgeBio Pharma
BBIO
$15.9B
| $343K | 0.01% |
+8,486
| New | +$255K |
|
1100
Knowles
KN
$2.85B
| $341K | 0.01% |
+19,056
| New | +$296K |
|
Similar funds
Joel Greenblatt's Q4 2023 Portfolio in Review
As of Q4 2023, Joel Greenblatt held 1,470 positions worth $5.39B, up 11% from $4.84B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Joel Greenblatt's Q4 2023 filing shows 157 new, 492 increased, 650 reduced and 145 closed positions. Its largest new stake was Fidelity Fundamental Small-Mid Cap ETF: 457,078 shares worth $4.99M. The largest sale was Pfizer, an estimated $14M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 19% a quarter earlier, followed by Industrials and Consumer Discretionary.
- Joel Greenblatt's largest Q4 2023 buy was Fidelity Fundamental Small-Mid Cap ETF: 457,078 shares worth $4.99M.
- Joel Greenblatt added most to BILL Holdings in Q4 2023, an estimated $41.5M increase.
- Joel Greenblatt's biggest Q4 2023 reduction was Pfizer, cutting an estimated $14M.
- Joel Greenblatt fully exited VMware, Inc in Q4 2023, selling an estimated $9.3M.
- Joel Greenblatt's ten largest holdings make up 24% of its $5.39B portfolio in Q4 2023.
- Joel Greenblatt opened 157 new positions and closed 145 in Q4 2023.
- Joel Greenblatt's portfolio value rose 11% quarter-over-quarter to $5.39B.
Based on Gotham Asset Management's 13F filing for Q4 2023, filed 14 Feb 2024.